KSCM
AMGN icon

Key Square Capital Management’s Amgen AMGN Stock Holding History

Key Square Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-252,800
Closed -$43.5M – 24
2017
Q2 		$43.5M Buy
+252,800
New +$41.1M 6.49% 6

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Key Square Capital Management's AMGN Position: Q3 2017 in Review

Key Square Capital Management sold out of Amgen (AMGN) in Q3 2017, closing a stake of 252,800 shares — an estimated $43.5M sold.

Key Square Capital Management first reported a position in AMGN in Q2 2017 and held it in 1 quarter. The position peaked at $43.5M in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Key Square Capital Management reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Key Square Capital Management sold 252,800 Amgen shares in Q3 2017, an estimated $43.5M.
  • Key Square Capital Management first reported a position in Amgen in Q2 2017 and held it in 1 quarter.
  • Key Square Capital Management's Amgen position peaked at $43.5M in Q2 2017.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Key Square Capital Management's 13F filing for Q3 2017, filed 7 Nov 2017.